A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Clinical trial NCT01399697 · COMPLETED

Trial details

NCT number: NCT01399697
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2011-09-01
Primary completion: 2014-05-01
Enrollment: 261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.